newsfilter
← Latest News
Business Wire·

Monsanto and NRGene Announce Global Licensing Agreement for Big Data Genomic Analysis Technology

ST. LOUIS & NESS ZIONA, Israel--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) and NRGene announced today that the companies have reached a non-exclusive, multi-year global licensing agreement on NRGene’s genome-analysis technology to enhance Monsanto’s ability to predict, compare and select the best genetic makeup from its vast data sets of genetic, genomic and trait information.